GSK plc
GLAXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,951 | $5,308 | $4,921 | $5,096 |
| Dep. & Amort. | $2,551 | $2,294 | $2,298 | $2,524 |
| Deferred Tax | $0 | $0 | -$1,236 | -$318 |
| Stock-Based Comp. | $344 | $307 | $346 | $343 |
| Change in WC | $2,090 | -$364 | $271 | -$473 |
| Other Non-Cash | -$1,382 | -$777 | $803 | $756 |
| Operating Cash Flow | $6,554 | $6,768 | $7,403 | $7,952 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,399 | -$1,314 | -$2,258 | -$2,931 |
| Net Acquisitions | $1,368 | -$1,384 | -$3,136 | $185 |
| Inv. Purchases | $0 | $0 | -$703 | $1,759 |
| Inv. Sales/Matur. | $21 | $72 | $1 | $18 |
| Other Inv. Act. | -$1,219 | $1,031 | -$2,676 | -$808 |
| Investing Cash Flow | -$1,229 | -$1,595 | -$8,772 | -$1,777 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,166 | -$2,370 | -$4,622 | -$2,003 |
| Stock Issued | $20 | $10 | $25 | $21 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$2,444 | -$2,247 | -$3,467 | -$3,999 |
| Other Fin. Act. | -$1,136 | -$1,034 | $8,887 | -$1,608 |
| Financing Cash Flow | -$4,726 | -$5,641 | $823 | -$7,589 |
| Forex Effect | -$54 | -$99 | $152 | -$29 |
| Net Chg. in Cash | $545 | -$567 | -$394 | -$1,443 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,858 | $3,425 | $3,819 | $5,262 |
| End Cash | $3,403 | $2,858 | $3,425 | $3,819 |
| Free Cash Flow | $3,572 | $4,424 | $5,145 | $5,021 |